Bit Origin
BTOG
Argo Blockchain
ARBK
Intchains Group
ICG
Bitfarms
BITF
CleanSpark
CLSK
US Stock MarketDetailed Quotes
CERO CERo Therapeutics
- 1.470
- +0.010+0.68%
Close Mar 7 16:00 ET
- 1.480
- +0.010+0.68%
Post 20:01 ET
4.45MMarket Cap0.00P/E (TTM)
1.490High1.410Low62.35KVolume1.480Open1.460Pre Close90.58KTurnover2.54%Turnover Ratio0.00P/E (Static)3.03MShares376.00052wk High-0.61P/B3.61MFloat Cap1.33052wk Low--Dividend TTM2.45MShs Float1280.000Historical High--Div YieldTTM5.48%Amplitude1.330Historical Low1.452Avg Price1Lot Size
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
CERo Therapeutics Stock Forum
Will This New AML Treatment Strategy Transform Blood Cancer Therapy? CERo Takes Critical Step
CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to Manage Translational Assays
Thursday, 6th March at 8:15 am
Company continues toward the initiation of its Phase 1 Clinical Trial in AML for CER-1236
SOUTH SAN FRANSCISCO, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ: CERO) ("CERo" or the "Company") an innovati...
CERo Therapeutics Holdings, Inc. to Present Data at the Society for Immunotherapy of Cancer Spring Scientific March 12-14
Wednesday, 5th March at 8:15 am
New poster to highlight preclinical data of CER-1236 in ovarian cancer
SOUTH SAN FRANSCISCO, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ: CERO) ("CERo" or the "Company") an innovative immunotherapy company seeking to advance the next generation of engineered T cell therap...
Major Cancer Treatment Breakthrough: CERo's Next-Gen Therapy Heads to Clinical Trials with Fresh Funding
No comment yet